| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-10 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-10 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.27 | 6e-09 |